192 related articles for article (PubMed ID: 10654498)
1. Biocompatibility of silicone-coated oxygenator in cardiopulmonary bypass.
Shimamoto A; Kanemitsu S; Fujinaga K; Takao M; Onoda K; Shimono T; Tanaka K; Shimpo H; Yada I
Ann Thorac Surg; 2000 Jan; 69(1):115-20. PubMed ID: 10654498
[TBL] [Abstract][Full Text] [Related]
2. Release of proinflammatory cytokines during pediatric cardiopulmonary bypass: heparin-bonded versus nonbonded oxygenators.
Ashraf S; Tian Y; Cowan D; Entress A; Martin PG; Watterson KG
Ann Thorac Surg; 1997 Dec; 64(6):1790-4. PubMed ID: 9436574
[TBL] [Abstract][Full Text] [Related]
3. Influence of two different perfusion systems on inflammatory response in pediatric heart surgery.
Jensen E; Andréasson S; Bengtsson A; Berggren H; Ekroth R; Lindholm L; Ouchterlony J
Ann Thorac Surg; 2003 Mar; 75(3):919-25. PubMed ID: 12645717
[TBL] [Abstract][Full Text] [Related]
4. PMEA coating of pump circuit and oxygenator may attenuate the early systemic inflammatory response in cardiopulmonary bypass surgery.
Ueyama K; Nishimura K; Nishina T; Nakamura T; Ikeda T; Komeda M
ASAIO J; 2004; 50(4):369-72. PubMed ID: 15307550
[TBL] [Abstract][Full Text] [Related]
5. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits.
Aldea GS; Soltow LO; Chandler WL; Triggs CM; Vocelka CR; Crockett GI; Shin YT; Curtis WE; Verrier ED
J Thorac Cardiovasc Surg; 2002 Apr; 123(4):742-55. PubMed ID: 11986603
[TBL] [Abstract][Full Text] [Related]
6. Heparin-coated circuits reduce the formation of TNF alpha during cardiopulmonary bypass.
Yamada H; Kudoh I; Hirose Y; Toyoshima M; Abe H; Kurahashi K
Acta Anaesthesiol Scand; 1996 Mar; 40(3):311-7. PubMed ID: 8721461
[TBL] [Abstract][Full Text] [Related]
7. The impact of allogenic red cell transfusion and coated bypass circuit on the inflammatory response during cardiopulmonary bypass: a randomized study.
Senay S; Toraman F; Gunaydin S; Kilercik M; Karabulut H; Alhan C
Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):93-9. PubMed ID: 18801802
[TBL] [Abstract][Full Text] [Related]
8. Biocompatibility of poly2methoxyethylacrylate coating for cardiopulmonary bypass.
Noguchi M; Eishi K; Tada S; Yamachika S; Hazama S; Izumi K; Tanigawa K
Ann Thorac Cardiovasc Surg; 2003 Feb; 9(1):22-8. PubMed ID: 12667126
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL
Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of a silicone coated hollow fiber oxygenator.
Shimono T; Shomura Y; Tani K; Shimamoto A; Hioki I; Tokui T; Onoda K; Takao M; Shimpo H; Yada I
ASAIO J; 1997; 43(5):M735-9. PubMed ID: 9360143
[TBL] [Abstract][Full Text] [Related]
11. Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass.
Steinberg BM; Grossi EA; Schwartz DS; McLoughlin DE; Aguinaga M; Bizekis C; Greenwald J; Flisser A; Spencer FC; Galloway AC
Ann Thorac Surg; 1995 Sep; 60(3):525-9. PubMed ID: 7677475
[TBL] [Abstract][Full Text] [Related]
12. Synthetic protein treated versus heparin coated cardiopulmonary bypass surfaces: similar clinical results and minor biochemical differences.
Wimmer-Greinecker G; Matheis G; Martens S; Oremek G; Abdel-Rahman U; Moritz A
Eur J Cardiothorac Surg; 1999 Aug; 16(2):211-7. PubMed ID: 10485423
[TBL] [Abstract][Full Text] [Related]
13. Drew-Anderson technique attenuates systemic inflammatory response syndrome and improves respiratory function after coronary artery bypass grafting.
Richter JA; Meisner H; Tassani P; Barankay A; Dietrich W; Braun SL
Ann Thorac Surg; 2000 Jan; 69(1):77-83. PubMed ID: 10654491
[TBL] [Abstract][Full Text] [Related]
14. Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass.
Hatori N; Yoshizu H; Haga Y; Kusama Y; Takeshima S; Segawa D; Tanaka S
Artif Organs; 1994 Dec; 18(12):904-10. PubMed ID: 7887827
[TBL] [Abstract][Full Text] [Related]
15. Hemocompatibility of PMEA coated oxygenators used for extracorporeal circulation procedures.
Zimmermann AK; Aebert H; Reiz A; Freitag M; Husseini M; Ziemer G; Wendel HP
ASAIO J; 2004; 50(3):193-9. PubMed ID: 15171468
[TBL] [Abstract][Full Text] [Related]
16. Duroflo II heparin bonding does not attenuate cytokine release or improve pulmonary function.
Butler J; Murithi EW; Pathi VL; MacArthur KJ; Berg GA
Ann Thorac Surg; 2002 Jul; 74(1):139-42. PubMed ID: 12118746
[TBL] [Abstract][Full Text] [Related]
17. Influence of PMEA-coated bypass circuits on perioperative inflammatory response.
Ninomiya M; Miyaji K; Takamoto S
Ann Thorac Surg; 2003 Mar; 75(3):913-7; discussion 917-8. PubMed ID: 12645716
[TBL] [Abstract][Full Text] [Related]
18. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
[TBL] [Abstract][Full Text] [Related]
19. Biocompatibility of heparin-coated circuits in pediatric cardiopulmonary bypass.
Kagisaki K; Masai T; Kadoba K; Sawa Y; Nomura F; Fukushima N; Ichikawa H; Ohata T; Suzuki K; Taketani S; Matsuda H
Artif Organs; 1997 Jul; 21(7):836-40. PubMed ID: 9212969
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory mediators in adults undergoing cardiopulmonary bypass: comparison of centrifugal and roller pumps.
Ashraf S; Butler J; Tian Y; Cowan D; Lintin S; Saunders NR; Watterson KG; Martin PG
Ann Thorac Surg; 1998 Feb; 65(2):480-4. PubMed ID: 9485250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
